Araceli Biosciences is a developer of scientific tools for tissue and cell-based biomarker discovery, drug discovery, and drug development.
Araceli Biosciences has raised $12.2M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Araceli Biosciences's investors include Bill Cortelyou.
Araceli Biosciences is headquartered in Tigard, United States.
Araceli Biosciences is a developer of scientific tools for tissue and cell-based biomarker discovery, drug discovery, and drug development.
Araceli Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Araceli Biosciences — Funding & Investors." VCBacked, April 24, 2025, https://www.vcbacked.co/company/araceli-biosciences. Accessed August 14, 2026.
VCBacked. (2025). Araceli Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/araceli-biosciences
{{cite web |title=Araceli Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/araceli-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated